Hye-Kyung Park
Overview
Explore the profile of Hye-Kyung Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
135
Citations
1609
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang Y, Kim H, Lee C, Jung J, Moon J, Park S, et al.
World Allergy Organ J
. 2025 Feb;
18(1):100990.
PMID: 39896201
Background: Eosinophils are crucial in allergic inflammation, and their correlation with asthma severity has made them a focal point in predicting treatment outcomes. Blood eosinophil count is a commonly utilized...
2.
Lee H, Lee Y, Lee S, Sim D, Kang N, Lee B, et al.
J Allergy Clin Immunol Pract
. 2025 Jan;
13(3):533-541.e3.
PMID: 39800057
Background: The prevalence and clinical implications of chronic cough (CC) in patients with severe asthma receiving asthma treatment remain relatively unknown. Objective: This study aimed to evaluate the relationships between...
3.
Thi Le H, Yu J, Ahn H, Kim M, Chae I, Cho H, et al.
Mol Cells
. 2025 Jan;
48(2):100176.
PMID: 39756584
Eukaryotic translation initiation factor 2α (eIF2α) phosphorylation, which regulates all 3 unfolded protein response pathways, helps maintain cellular homeostasis and overcome endoplasmic reticulum (ER) stress through transcriptional and translational reprogramming....
4.
Shim J, Kim S, Kim S, Lee T, Jang A, Park C, et al.
Allergy Asthma Immunol Res
. 2024 Dec;
16(6):601-612.
PMID: 39622685
Purpose: Despite the emerging biologics, biomarkers and treatment options for asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) are still limited, requiring further research. Methods: We enrolled 378 ACO patients from...
5.
Choi D, Kim A, Park S, Kim J, An J, Kwon J, et al.
Allergy
. 2024 Nov;
79(12):3512-3516.
PMID: 39513670
No abstract available.
6.
Rhyou H, Kim H, Song W, Lee S, Kim S, Kwon J, et al.
World Allergy Organ J
. 2024 Sep;
17(9):100957.
PMID: 39252792
Background: Anti-type 2 (T2) biologic therapies (biologics) improve exacerbation rates, lung function, and asthma-related quality of life (QoL) in patients with severe T2 asthma. However, studies comparing different biologics are...
7.
Kim H, Shim J, Park G, Kang D, Shin J, Kim S, et al.
J Allergy Clin Immunol Pract
. 2024 Aug;
12(12):3436-3438.e3.
PMID: 39197748
No abstract available.
8.
An J, Lee C, Kim S, Park S, Kim S, Sim D, et al.
Allergy Asthma Immunol Res
. 2024 Jun;
16(3):308-316.
PMID: 38910288
The diagnosis of anaphylaxis is based on the clinical history. The utility of tryptase measurements in clinical setting is limited. Mas-related G protein-coupled receptor-X2 (MRGPRX2) is expressed in mast cells...
9.
Park M, Park H, Yu H
J Inflamm Res
. 2024 May;
17:2915-2925.
PMID: 38764493
Background: Repeated exposure to recombinant profilin from (rAc-PF) induces allergic airway responses in vitro and in vivo. Based on the role of toll-like receptors (TLRs) in allergic airway diseases, TLRs...
10.
Park S, Park S, Seo S, Kwon H, Kim S, Kim S, et al.
World Allergy Organ J
. 2024 Apr;
17(5):100901.
PMID: 38638799
Background: Drug-induced hypersensitivity such as anaphylaxis is an important cause of drug-related morbidity and mortality. Cefaclor is a leading cause of drug induced type I hypersensitivity in Korea, but little...